Repare Therapeutics Inc. (RPTX)
NASDAQ: RPTX · Real-Time Price · USD
2.215
-0.015 (-0.67%)
At close: Dec 5, 2025, 4:00 PM EST
2.130
-0.085 (-3.84%)
After-hours: Dec 5, 2025, 5:21 PM EST
Repare Therapeutics Market Cap
Repare Therapeutics has a market cap or net worth of $95.21 million as of December 5, 2025. Its market cap has decreased by -23.03% in one year.
Market Cap
95.21M
Enterprise Value
-17.05M
1-Year Change
-23.03%
Ranking
Category
Stock Price
$2.22
Market Cap Chart
Since June 19, 2020, Repare Therapeutics's market cap has decreased from $945.76M to $95.21M, a decrease of -89.93%. That is a compound annual growth rate of -34.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 95.86M | 72.13% |
| Dec 31, 2024 | 55.69M | -81.89% |
| Dec 29, 2023 | 307.55M | -50.18% |
| Dec 30, 2022 | 617.25M | -29.87% |
| Dec 31, 2021 | 880.19M | -30.20% |
| Dec 31, 2020 | 1.26B | 33.34% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |